A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in ...

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

New research from CSHL, WashU Medicine and their collaborators reveals a circuit in the brainstem that can sense inflammation ...

Cachexia not only contributes to reduced quality of life but also limits a patient’s ability to tolerate or benefit from ...

This loss of motivation doesn’t just deepen patients’ suffering, it isolates them from family and friends. Because patients ...

Advanced cancer often leads to cachexia, a syndrome causing profound apathy in patients. New research reveals that cancer hijacks brain circuits controlling motivation, suggesting potential treatments ...

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a Phase 2 trial for its experimental drug ...

Scientists identify a brain pathway linking inflammation to fatigue, low energy, and loss of motivation in advanced cancer patients.

Researchers at WashU Medicine identified a direct connection between cancer-related inflammation and the loss of motivation ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, ...

A cruel consequence of advanced cancer is the profound apathy many patients experience as they lose interest in once-cherished activities. This symptom is part of a syndrome called cachexia ...